Synthexim is located at Calais, in the Pas-de-Calais region of France.
Synthexim is classified as high threshold (Seveso II), audited by the French Medicines Agency (AFSSAPS) with reactors with a total capacity of 52 m3.
Employing 36 people, Synthexim manufactures:
-
pharmaceutical advanced intermediates and APIs
-
pharmaceutical derivatives of 8-hydroxyquinoline